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The murine Flavivirus Modoc replicates well in Vero cells and appears to be as equally sensitive as both yellow fever and
dengue fever virus to a selection of antiviral agents. Infection of SCID mice, by either the intracerebral, intraperitoneal, or
intranasal route, results in 100% mortality. Immunocompetent mice and hamsters proved to be susceptible to the virus only
when inoculated via the intranasal or intracerebral route. Animals ultimately die of (histologically proven) encephalitis with
features similar to Flavivirus encephalitis in man. Viral RNA was detected in the brain, spleen, and salivary glands of infected
SCID mice and the brain, lung, kidney, and salivary glands of infected hamsters. In SCID mice, the interferon inducer poly IC
protected against Modoc virus-induced morbidity and mortality and this protection was associated with a reduction in
infectious virus content and viral RNA load. Infected hamsters shed the virus in the urine. This allows daily monitoring of
(inhibition of) viral replication, by means of a noninvasive method and in the same animal. The Modoc virus model appears
attractive for the study of chemoprophylactic or chemotherapeutic strategies against Flavivirus infections. © 2001 Academic
Press
Key Words: Flavivirus; Modoc; antiviral therapy; West Nile virus; tick-borne encephalitis virus; Japanese encephalitis virus.
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Flaviviruses are enveloped, positive single-stranded
RNA viruses that belong, together with the Hepaci- and
Pestiviruses, to the family of the Flaviviridae (Trepo et al.,
997; Rice, 1996). Based on phylogenetic analysis of 58
embers, the genus Flavivirus was subdivided into three
lusters: the mosquito-borne, the tick-borne, and the
o-vector clusters (Kuno et al., 1998). Viruses belonging
o the first two cluster have a complex natural transmis-
ion cycle, which involves several natural hosts (mostly
ammals or birds) and vector(s), the latter being blood-
ucking insects such as ticks or mosquitoes (Monath
nd Heinz, 1996).
Flaviviruses have a worldwide distribution and several
f them have a major impact on human health. The WHO
stimates that each year about 50 million people be-
ome infected with the dengue fever virus (DENV) (http://
ww.who.int/inf-fs/en/fact117.html). At least 500,000
ases of dengue hemorrhagic fever (DHF) or dengue
hock syndrome (DSS) are reported annually, of which
5% may have a fatal outcome, mainly in children under
he age of 15 (Halstead, 1992). Despite the existence of
n effective vaccine, the yellow fever virus (YFV) causes
ore than 5000 cases a year with a mortality of 50%
Monath, 1987). For the Japanese encephalitis virus (JEV),
1 To whom correspondence and reprint requests should be ad-
ressed at Rega Institute for Medical Research, Minderbroedersstraata
2
0, Leuven B-3000, Belgium. Fax: (32) 16-33.73.40. E-mail:
ohan.neyts@rega.kuleuven.ac.be.
27an estimated 30,000 people a year become infected,
despite the availability of a vaccine. The mortality rate
associated with JEV infections is 30% and an additional
30% of the survivors suffer from long-lasting neurological
sequelae (Schneider et al., 1974; Kalita and Misra, 1998).
There are two subtypes of tick-borne encephalitis virus
(TBEV): the Far Eastern, also referred to as Russian
spring-summer encephalitis virus (RSSEV), and the Eu-
ropean, referred to as central European encephalitis
virus (CEEV). TBEV is transmitted to humans usually by
the bite of a tick or occasionally following consumption
of unpasteurized milk. The mortality rates associated
with the Far Eastern subtype and the European subtype
are about 30 and 1–2%, respectively (Heinz and Mandl,
1993; Dumpis et al., 1999; Ecker et al., 1999).
Although the last large epidemic of Murray Valley
ncephalitis (MVEV) occurred in 1974, new cases of
VEV are regularly reported, especially in Western Aus-
ralia (Mackenzie and Broom, 1995). The West Nile virus
WNV) is mainly endemic around the Mediterranean Sea,
frica, and the Middle East. In 1996, an outbreak of WNV
ccurred in Romania with 393 cases, of which 352 were
ith acute CNS involvement and 17 with fatal outcome
Tsai et al., 1998; Han et al., 1999). More recently (late
ugust–September 1999), an outbreak of WNV caused
ver 1900 serologically proven infections in the New York
etropolitan area, of whom 77 had to be hospitalized
ith signs of encephalitis and of whom 7 died (Briese etl., 1999; Lanciotti et al., 1999). During the late summer of
000, 17 more cases (1 death) were reported in New
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28 LEYSSEN ET AL.York. From July to September 1999, an outbreak of me-
ningoencephalitis associated with WNV occurred in
Southern Russia with hundreds of cases and dozens of
deaths (Lvov et al., 2000). In the late summer and early
all of 2000, an outbreak in Israel was responsible for
ore than 169 cases and 12 deaths (Siegel, 2000).
Although there are no recent reports of outbreaks or
pidemics of Saint Louis encephalitis virus (SLEV), the
irus causing this disease is endemic in the western
egion of the United States and is responsible for severe
isease (Kramer et al., 1997). The Powassan encephalitis
virus (POWV), transmitted by ticks, is endemic in Ontario
and in the Southern Far East of Russia and may cause
encephalitis after a period of fever and nonspecific
symptoms (Mandl et al., 1993; Kolski et al., 1998). Thou-
ands of cases of infections with the Kyasanur Forest
isease virus (KFDV, endemic in India) have been re-
orted since the discovery of the virus in 1957. The
nnual incidence of virologically diagnosed cases is
00–500, with a case fatality rate of 3–5% (Pavri, 1989;
anerjee, 1996; Monath and Heinz, 1996). A small num-
er of cases of Omsk hemorrhagic fever (OHFV) occur
ach year among rural residents in the Omsk region in
ussia (Monath and Heinz, 1996). Louping ill virus (LIV) is
rimarly a disease in sheep, although there have been at
east 37 documented cases in man. The infection was
robably acquired during laboratory experiments or di-
gnosis (Davidson et al., 1991; McGuire et al., 1998).
Despite the clinical impact of Flavivirus infections,
here is as yet no effective therapy. The study of antiviral
hemoprophylaxis or chemotherapy is hindered by the
ack of a convenient small animal model.
Experimental infection of mice with JEV, YFV, or TBEV
y intracerebral or peripheral inoculation was reported to
ause morbidity and mortality. However, use of these
ighly pathogenic viruses (BSL-3 or BSL-4), for man,
equires special laboratory facilities (Holzmann et al.,
990; Higgs and Gould, 1991; Kaluzova et al., 1994).
ttenuated strains of YFV or DENV (BSL-2) may cause
orbidity and even mortality in small laboratory animals,
ut only when the virus is inoculated directly into the
rain of newborn or suckling mice (Kawano et al., 1993;
ray et al., 1998). Several models were previously de-
cribed for DENV infection in mice, although most of
hese are labor intensive because of the use of human
umor cell engraftment (Lin et al., 1998; An et al., 1999;
ohnson and Roehrig, 1999).
We here present a novel and convenient model for the
tudy of new strategies for the treatment of infections
ith flaviviruses and in particular Flavivirus encephalitis.
o this end, we employed the murine Flavivirus Modoc.
he Modoc virus (MODV) was previously isolated from
hite-footed deer mice (Peromyscus maniculatus) col-
ected in Modoc County, California, in 1958 (Johnson,
967). Later on the virus was also isolated from deer
ice trapped in the wild in Oregon, Montana, Colorado,
M
Tnd Alberta (Canada) (Zarnke and Yuill, 1985). Neutral-
zation tests using blood samples isolated from mam-
als trapped in Alberta as well as from humans indicate
he appearance of natural infection without disease
Zarnke and Yuill, 1985). No arthropod vector was previ-
usly demonstrated (Johnson, 1967). Based on cross-
erological reactivity, the virus was classified as a Flavi-
irus (Casals, 1960; Varelas and Calisher, 1982; Calisher
t al., 1989). A phylogenetic analysis based on an ;1-kb
ragment of 58 flaviviruses showed that MODV belongs
o the no-vector cluster of flaviviruses. The no-vector and
he vector-transmitted viruses have a common ancestor
Kuno et al., 1998).
We determined the complete genomic sequence of the
odoc virus (to be published elsewhere). An overall
equence similarity with the tick-borne and mosquito-
orne flaviviruses of 54.3 and 52.3%, respectively, was
alculated. This is comparable to the sequence similarity
etween mosquito-borne (including YFV, DENV, JEV,
NV, MVEV, KUNV) and tick-borne (TBEV, POWV, LIV)
laviviruses, which is 53.7%. Furthermore, based on our
equence data, the Modoc virus has the same genomic
rganization and conserved motifs for enzymatic activity
s the human flaviviruses. In the present study, we es-
ablished an infection model for MODV in SCID mice and
amsters. This model may be attractive for the study of
ntiviral strategies against Flavivirus infections, particu-
arly Flavivirus encephalitis.
RESULTS
ntiviral susceptibility
MODV produces a clear cytopathic effect in Vero cells.
o study whether the replication of MODV is equally
usceptible to a selection of antiviral agents as the
eplication of human flaviviruses, we compared the in-
ibitory effects of ribavirin, EICAR (the 59-ethynyl deriva-
ive of ribavirin) (De Clercq et al., 1991), tiazofurin, selena-
ofurin (an oncolytic C-nucleoside), and mycophenolic
cid (MPA, an inhibitor of IMP-dehydrogenase) on the
eplication of YFV, DENV, and MODV. As can be derived
rom Table 1, the antiviral efficacy of the different com-
ounds against YFV, DENV, and MODV ranked as fol-
ows: mycophenolic acid . EICAR . selenazofurin .
ibavirin . tiazofurin. This result was confirmed by a
ytopathic effect (CPE) reduction test (data not shown).
he susceptibility of MODV to these compounds proved
ore or less comparable to the susceptibility of the
uman flaviviruses YFV and DENV to these drugs.
etection of Modoc virus by means of RT-PCR with
lavivirus-specific primers
Total RNA was extracted from the supernatant of
ODV-infected Vero cells that showed extensive CPE.
his RNA was subjected to RT-PCR using a set of uni-
29MODOC VIRUS INFECTIONSversal Flavivirus primers (Pierre et al., 1994). Amplicons
of YFV had a size of 674 bp; RT-PCR on RNA extracted
from DENV-2-infected cultures produced two bands, one
of 641 bp and another one of 554 bp; and RT-PCR on RNA
isolated from MODV-infected cultures yielded a fragment
of 483 bp (data not shown). This latter fragment was
sequenced. An overall sequence similarity of 57.9 and
65.5% with DENV and YFV, respectively, was calculated.
The entire sequence of the Modoc virus genome will be
published elsewhere. The reasons for the different
lengths of the fragments are the variation of the se-
quence and the size of the 39 UTR of the viral genome
where the primer VD8 binds (GenBank accession num-
ber DENV: M84727; YFV: U54798; MODV: our unpub-
lished results).
Modoc virus infections in mice
The effect of different routes of inoculation with MODV
on morbidity and mortality in SCID and NMRI mice,
respectively, was studied. Direct intracerebral inocula-
tion of the virus (104 PFU), in both SCID and NMRI mice,
led to paralysis within 6 days and mortality within 9 days
[Figs. 1A and 1B; mean day of paralysis (MDP): 6.2 6 0.4
(SCID) and 6.3 6 0.4 (NMRI); mean day of death (MDD):
9.0 6 0.4 (SCID) and 9.4 6 0.5 (NMRI); 25 animals].
Morbidity was characterized by ruffled fur, paralysis of
the hind legs, and a wasting syndrome. Intraperitoneal
(i.p.) and intranasal (i.n.) infection of SCID mice with
MODV resulted in morbidity [Fig. 1A; MDP: 10.8 6 0.6 (i.p.
route, .50 animals), 11.8 6 0.4 (i.n. route, .15 animals)]
and mortality [MDD: 12.8 6 1.3 (i.p. route), 13.4 6 0.5
(i.n. route)]. Immunocompetent NMRI mice, infected via
intraperitoneal inoculation, remained healthy throughout
the experiment. When NMRI mice were inoculated via
the intranasal route, 55% of the animals developed pa-
ralysis [MDP: 11.6 6 0.5 (11 animals)] and ultimately died
as a result of CNS involvement (MDD: 12.8 6 0.8) (Fig.
TABLE 1
Susceptibility of the Modoc Virus, YFV and DENV
to Different Antiviral Agents
EC50 (mg/ml)
a
Antiviral agent Modoc virus YFV DENV
Ribavirin 34 6 17 22 6 14 38 6 11
EICAR 1.0 6 0.6 0.8 6 0.4 1.6 6 0.6
Mycophenolic acid 0.05 6 0.03 0.06 6 0.04 0.10 6 0.06
Tiazofurin 48 6 18 17 6 9 73 6 25
Selenazofurin 11 6 4 2.6 6 1.1 12 6 5
a Concentration required to reduce virus-induced plaque formation
on Vero cells by 50%.1B).
We next wanted to monitor viral replication in differentorgans. Because organ extracts cause some toxicity on
cell cultures in which the titration is performed, the de-
tection limit of this methodology appeared to be ;100
PFU/100 mg tissue. We therefore decided to monitor viral
replication by means of RT-PCR [detection limit 10 fg of
viral RNA (data not shown)]. Total RNA was extracted
from the brain, salivary glands, lung, liver, kidney, and
spleen of intraperitoneally infected SCID mice that ex-
hibited obvious signs of paralysis. Following RT-PCR,
viral RNA was detected in the brain, salivary glands, and
spleen. No, or very little, viral replication was detected in
FIG. 1. Paralysis (M) and mortality (f) following intracerebral (i.c.),
intraperitoneal (i.p.), or intranasal (i.n.) inoculation of SCID mice (A),
NMRI mice (B), and hamsters (C) with MODV. NT 5 not tested.
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30 LEYSSEN ET AL.the lungs, liver, and kidneys (Fig. 2A). Next, the progres-
sion of infection was monitored in the brain and spleen
of SCID mice that had been infected intraperitoneally
with MODV. Two mice were terminated daily (from Day 1
to Day 10 postinfection) and total RNA was extracted and
subjected to RT-PCR. Viral RNA first became detectable
in the spleen at 5 days postinfection. In the brain, viral
RNA became detectable at 9 days postinfection. Signs of
paralysis developed about 2 days later (i.e., on Day 11
postinfection; data not shown).
Modoc virus infection in hamsters
Although immunocompetent, 50–60% of 8- to 12-week-
old hamsters that had been inoculated intraperitoneally
or intranasally with MODV became sick, developed signs
of paralysis, and ultimately died because of encephalitis
[intraperitoneal inoculation: MDP 5 9.2 6 0.8; MDD 5
1.9 6 1.3 (18 animals); intranasal inoculation: MPD 5
.8 6 0.4; MDD 5 13.7 6 2.9 (7 animals)] (Fig. 1C). Total
NA extracted from the organs of three moribund ani-
als was subjected to RT-PCR. Viral RNA was detected
n the brain, salivary glands, lungs, and kidneys (Fig. 2B).
ecause viral RNA was also detected in the kidneys, in
next set of experiments, we collected urine samples
uring the course of the infection. RNA was extracted
rom these samples and subjected to RT-PCR. From Day
postinfection, viral RNA became detectable in the urine
fter which the signal intensified for several days, sug-
esting increasing viral titers (Fig. 3A). Detection of viral
NA in the urine is consistent with the detection of the
irus in the kidneys. Using TaqMan technology for quan-
itative RT-PCR, a very low viral RNA load was detectable
s of Days 3 and 4 postinfection, whereafter viral RNA
iters (quantified as PCR-units 5 lowest template copy
umber detectable in five of five replicate reactions de-
ermined by limiting dilution series) sharply increased up
FIG. 2. Detection of viral RNA in different organs of animals infected
ith MODV via the intraperitoneal route. Organs were collected at the
ime the animals showed fulminant encephalitis. RNA was detected by
eans of RT-PCR. Lane 1, brain; lane 2, salivary gland; lane 3, lung; lane
, liver; lane 5, kidney; and lane 6, spleen. (A) SCID mice, 10 days
ostinfection. (B) Hamsters, 11 days postinfection.o Day 8 postinfection (Fig. 3B). From Day 9 on, viral titers
tarted to drop. This is consistent with a markedly in-
A
ireased diuresis, resulting in an important dilution of
iral RNA (before Day 9, average urine volumes were
.1 6 0.8 ml and this increased to .50 ml urine/hamster/
day after Day 9 postinfection).
Histopathology
The brains of hamsters that had been infected with the
Modoc virus via intraperitoneal inoculation and that ex-
hibited obvious signs of encephalitis were studied his-
tologically. In parts of the cortex and bulbus olfactorius,
obvious destruction of the tissue was observed. In these
areas, infiltration of monocytes and lymphocytes was
noted. Infiltration with inflammatory cells was merely
observed in the gray matter of the cortex (Fig. 4B) and in
the bulbus olfactorius (Fig. 4C). Perivascular cuffing, one
of the characteristics of encephalitis induced by flavivi-
ruses, was observed in small or medium-size blood
vessels (Figs. 4D and 4E). The meninges were loosely
attached and swollen in the affected areas (Fig. 4B;
compare with Fig. 4A in a nonaffected area). The struc-
ture of the tissue was (almost) completely destroyed in
these areas (Fig. 4B). Around these acellular plaques
(endematous necrotic foci), degenerated or pyknotic
(deeply eosinophilic) neurons were observed, often in-
volved in neuronophagia or the formation of glial nod-
ules. Throughout the gray matter, groups of degenerating
neurons were detected (Fig. 4F). In the cerebellum, only
a small number of Purkinje neurons appeared to be
involved (Fig. 4G). Except for the olfactory bulbs, part of
the cortex and the cerebellum, no other major signs of
virus-induced pathology were noted in the brain. In the
spleen, large polymorphonuclear cells were detected in
FIG. 3. MODV RNA from Day 1 to Day 12 postinfection in the urine of
8- to 12-week-old hamsters (at each time point, the urine from four
animals was collected). (A) RT-PCR analysis of viral RNA extracted from
140 ml urine. (B) Quantitation of the viral RNA load in the urine by
TaqMan RT-PCR (means 6 SD of two replicate experiments). PCRU 5
CR-units. One PCR-unit is defined to be the lowest template copy
umber detectable in five of five replicate reactions as determined by
imiting dilution series. Values above bars indicate the mean values.
rrow indicates the day as of which an increased diuresis is observed
n infected animals.
q
i
s
t
g
e
w
i
f
m
h
u
o
d
d
(
o
5
n
r
h
t
C
a
m
o
o
d
t
a
c
v
p
31MODOC VIRUS INFECTIONSthe red pulpa (Fig. 4H). Whether this is a direct conse-
uence of the replication of the virus or the result of the
mmune response remains unclear. In the liver, extensive
teatosis was observed (Fig. 4I). No apparent his-
opathological changes were observed in the other or-
ans studied.
In SCID mice that exhibited obvious signs of Modoc
ncephalitis, however, little or no infiltration of the brain
ith lymphocytes was observed (data not shown). This is
n accordance with the fact that SCID mice do not have
unctional T and B cells. Also, despite the fact that these
ice had clinical signs of encephalitis, no other major
istopathological changes were noted. However, at the
ltrastructural level, severe changes in the neurons were
bserved (see below). This is in agreement with neuron
FIG. 4. Histological appearance (H&E) of the brain of MODV-infected
amsters and SCID mice at 10 days postinfection. (A) Cross section of
he cerebral cortex in a nonaffected area of hamster brain (3100). (B)
ross section of the cerebral cortex (same hamster as in A) in an
ffected area (acellular plaque), showing massive infiltration by inflam-
atory cells, loosely attached and swollen meninges, and destruction
f the normal tissue structure (3100). (C) Infiltration of the bulbus
lfactorius of a MODV-infected hamster by inflammatory cells and
estruction of the normal tissue structure (3100). (D) Cross section
hrough medium-size blood vessels in the gray matter of the cortex of
MODV-infected hamster at 15 days postinfection, showing perivas-
ular cuffing (3100). (E) Longitudinal section of a medium-size blood
essel in the gray matter of a MODV-infected hamster at 15 days
ostinfection, showing perivascular cuffing (3100). (F) Degenerated or
pyknotic (deeply eosinophilic) neurons accompanied by normal neu-
rons in the cerebral cortex of a MODV-infected SCID mouse at 11 days
postinfection (3180). (G) One normal and two degenerating Purkinje
cells in the cerebellum of a MODV-infected SCID mouse at 11 days
postinfection (3220). (H) Large polymorphonuclear cell in the red pulpa
of the spleen of a MODV-infected hamster at 15 days postinfection
(3220). (I) Steatosis of the liver of a MODV-infected hamster at 11 days
postinfection (3180).ysfunction, which leads to encephalitis and ultimately
eath.Ultrastructural analysis
MODV-infected Vero cell cultures were studied by
means of electron microscopy. Upon infection, the intra-
cellular organization appeared to be changed. Cellular
pathology was characterized, as compared to the cyto-
plasm of a noninfected cell, by extensive proliferation
and dilatation of the rough endoplasmic reticulum (RER)
(Fig. 5A and insert), which is a characteristic for cells
infected with a Flavivirus (Westaway, 1987; Chambers et
al., 1990). Large amounts of viral particles egressed from
FIG. 5. Ultrastructural analysis of (A) Vero cell 2 days postinfection,
showing dilated RER (scale bar 5 0.5 mm) compared to the RER of a
noninfected cell (arrows, insert); (B) Vero cell 3 days postinfection,
releasing large amounts of mature viral particles (scale bar 5 0.5 mm);
C) affected Purkinje cell surrounded by intact tissue in the cerebellum
f a MODV-infected SCID mouse at 11 days postinfection (scale bar 5
mm); (D) neuron (bottom right) located in an acellular plaque of the
cerebral cortex (tissue fragments) accompanied by a blood lymphocyte
(top left) and a mononuclear cell (bottom left) of a MODV-infected
hamster 15 days postinfection (scale bar 5 5 mm); (E) cytoplasm of a
ormal neuron of a SCID mouse (RER, top left; Golgi complex, bottom
ight; scale bar 5 1 mm); and (F) cytoplasm of an infected neuron of a
MODV-infected SCID mouse at 11 days postinfection, showing exten-
sive dilatation, proliferation, and hypertrophy of the RER and vesicle
structures containing virus-like particles (center right; scale bar 5
1 mm).
o
f
32 LEYSSEN ET AL.the cells 2–3 days after infection (Fig. 5B). The size of the
viral particles was determined to be about 45 nm, which
is very similar to the size of human flaviviruses (40–60
nm) (Monath and Heinz, 1996). Next, brain tissue sam-
ples from mice and hamsters that showed extensive
signs of encephalitis were examined for ultrastructural
changes. In the cerebellum of SCID mice and hamsters,
Purkinje cells show dilatation and hypertrophy of the RER
(Fig. 5C). In the cytoplasm of degenerative cortical neu-
rons from SCID mice and hamsters, accumulation of
vesicular structures, most likely derived from the ER or
Golgi complex, was observed. Furthermore, dilatation,
proliferation, and hypertrophy of the RER were noted (Fig.
5F), which is not the case in neurons of uninfected
animals (Fig. 5E). In the acellular plaques observed in
the brain of infected hamsters, mononuclear cells (mac-
rophages or microglial cells) and infiltrating blood lym-
phocytes were distinguished (Fig. 5D).
Effect of treatment with an interferon inducer on
Modoc virus replication and associated mortality
To validate the Modoc virus model for future use in
antiviral studies, we sought to assess whether a corre-
lation exists between the protective effect on morbidity
and mortality of a therapeutic or prophylactic agent, on
one hand, and an inhibitory effect on viral replication, on
the other hand. Treatment with ribavirin did not protect
mice from MODV-induced morbidity and mortality, nor
did it cause a reduction in viral RNA in the infected
organs (data not shown). We therefore studied the effect
of the interferon inducer poly IC. To this end, SCID mice
were treated with a single dose of poly IC at 15 mg/kg
and 24 h later were infected intraperitoneally with MODV.
Under these conditions, treatment with poly IC resulted
in significantly fewer animals that developed signs of
paralysis and also caused a 6- to 7-day delay in virus-
induced mortality. When poly IC was first given 1 day
TABLE 2
Effect of Pre- or Posttreatment with the Interferon-Inducer Poly IC
n MODV-Induced Morbidity and Mortality in Intraperitoneally In-
ected SCID Mice
Condition
Number
with
paralysis MDP
Number
of death MDD
VC 5/5 12.8 6 1.9 5/5 15.4 6 1.9
Pretreatment 9/15*** 15.1 6 2.0* 13/15NS 23.0 6 7.2**
Posttreatment 14/14 13.1 6 1.8NS 14/14 16.4 6 2.6NS
* P , 0.05, **P , 0.01, ***P , 0.001, NS 5 not significant.
Note. Adult SCID mice were either left untreated or treated intraperi-
toneally at Day 21 with 15 mg/kg poly IC (pretreatment condition) or at
Day 11 with 15 mg/kg poly IC (posttreatment condition).after the infection, all protective activity was lost (Table
2). In a parallel experiment, viral RNA was monitored (bymeans of RT-PCR) in the brain and spleen of MODV
infected SCID mice that had received either mock- or
poly IC treatment. Tissue samples were taken at a time
at which untreated controls develop signs of paralysis
(i.e., 11 days postinfection). Levels of viral RNA detected
in the brain and spleen of infected SCID mice were
FIG. 6. MODV RNA detected in the spleen and brain of MODV-
infected SCID mice that received pretreatment or posttreatment with
poly IC (experiment parallel to the experiment presented in Table 2). (A)
Gel electrophoresis of the amplicons obtained by OneStep RT-PCR. (B)
Semiquantitation of the viral load using GAPDH as an internal standard.
(C) Titration of 10% tissue homogenates on Vero cells for infectious
virus load (dotted line indicates threshold of detection). (D) Quantitation
of viral load using TaqMan technology (each bar represents the
means 6 SD of four replicate experiments).
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33MODOC VIRUS INFECTIONSmarkedly reduced in those animals that had been pre-
treated with poly IC as was assessed by means of
semiquantitative RT-PCR (Figs. 6A and 6B), by quantita-
tive RT-PCR (TaqMan technology) (Fig. 6D) and by titra-
tion for infectious virus content (Fig. 6C). Thus, a protec-
tive effect of poly IC on virus-induced morbidity and
mortality translates in a reduction of titers of infectious
virus and viral RNA.
DISCUSSION
The availability of a convenient small animal model
would be very useful for the study of strategies for the
treatment or prevention of Flavivirus infections. Monkeys
infected with flaviviruses such as YFV, DENV, or JEV may
develop infection, but because of the cost involved and
the restricted availability of monkeys, the number of
studies that can be carried out by using these animals is
limited. Some flaviviruses (e.g., DENV, YFV) cause mor-
bidity and mortality in mice, but only when inoculated
intracerebrally and when virus strains are used that have
been adapted by serial passage in the brain of suckling
mice. Other flaviviruses (e.g., TBEV, JEV) may cause in-
fection in mice following peripheral inoculation, although
these viruses require high containment laboratory facil-
ities, which is of course an obstacle for intensive re-
search with animals. The Modoc virus was first isolated
from deer mice in Colorado in 1958 (Johnson, 1967) and,
except for some initial reports, no further research has
been carried out with this virus. Based on cross-serology,
the Modoc virus was classified as a Flavivirus (Casals,
1960; Varelas and Calisher, 1982; Calisher et al., 1989). In
a comparative study, Kuno and colleagues (1998) ampli-
fied an ;1-kb fragment of the genome of 58 different
laviviruses, including MODV, using a primer set that
nneals to the highly conserved 39 region of the Flavivi-
rus genome. Phylogenetic analysis based on these se-
quences revealed that MODV belongs to the no-vector
cluster, which further branches into three clades, all of
which are murine or bat-associated viruses (Kuno et al.,
1998).
The Modoc virus can be readily propagated in Vero
cells and elicits an obvious cytopathic effect. MODV virus
replication appeared to be more or less as equally sen-
sitive as YFV and DENV to the inhibitory activity of dif-
ferent drugs that inhibit Flavivirus replication, including
ribavirin, EICAR (the 5-ethynyl analog of ribavirin), and
mycophenolic acid (MPA). The overall genome organiza-
tion of MODV is similar to that of other flaviviruses (our
unpublished results) and genes that encode potential
antiviral targets such as the NS3 (encoding the protease,
NTPase, and helicase) and NS5 (encoding the methyl-
transferase and RNA-dependent RNA polymerase) con-
tain the same conserved motifs for enzymatic activity as
those of flaviviruses that are important human pathogens
(e.g., dengue fever virus, Japanese encephalitis virus,
w
etick-borne encephalitis virus). Since these enzymatic ac-
tivities imply specific catalytic residues and configura-
tions of amino acids in the active site, antiviral agents
that may be active against one Flavivirus may also be
expected to show broad-spectrum activity against other
flaviviruses (as we demonstrate in cell culture experi-
ments; see Table 1). Only those drugs that show broad-
spectrum anti-Flavivirus activity would be of interest for
further development. Such drugs could then be easily
evaluated in the Modoc models, which may be instru-
mental in the preclinical development of anti-Flavivirus
drugs.
The Modoc virus particle has a size of ;45 nm, which
is comparable to the size of other flaviviruses (40–60 nm)
(Monath and Heinz, 1996). Ultrastructurally, infected cells
show changes (proliferation of the endoplasmic reticu-
lum) similar to those observed in cells infected with other
flaviviruses (Westaway, 1987; Chambers et al., 1990).
In immunocompetent mice (here NMRI), MODV
causes morbidity and mortality, which is 100% when virus
is inoculated directly into the brain and 55% when inoc-
ulated via the intranasal route. However, MODV appears
to be highly pathogenic to SCID mice when inoculated
peripherally (i.e., via either the intraperitoneal or the
intranasal route, 100% mortality). Viral replication is de-
tected in the salivary glands and spleen of infected SCID
mice and, in a later stage, the virus becomes detectable
in the brain, followed a couple of days later by death as
a result of CNS involvement. Although no major his-
topathological changes were observed in the brains of
SCID mice that had obvious signs of Modoc virus-in-
duced encephalitis, ultrastructural analysis of the neu-
rons clearly revealed a cellular pathology characteristic
for Flavivirus infection.
Although immunocompetent mice are not susceptible
to the virus when infected via the intraperitoneal route,
50–60% of the inoculated hamsters became sick and
died (as a result of CNS involvement) after intranasal or
intraperitoneal inoculation with the virus. MODV-induced
encephalitis in hamsters was characterized by infiltration
of the cortex and bulbus olfactorius by monocytes and
ymphocytes and massive destruction of the tissue struc-
ure. Large polymorphonuclear cells could be detected in
he spleen and extensive steatosis was observed in the
iver. Interestingly, the virus was shed in the urine of
hese infected hamsters (and not SCID mice). This is in
greement with detection of viral RNA in the kidneys of
nfected hamsters. That the virus is shed in the urine of
nfected hamsters offers the possibility to assess the
ffect of therapy on viral replication in one and the same
nimal and over a relatively long time span, simply by
daily) monitoring of viral RNA in the urine (by means of
he quantitative RT-PCR assay we have established).
To validate the SCID model for use in antiviral studies,
e sought to prove that protection against MODV dis-
ase progression, brought about by either a therapeutic
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34 LEYSSEN ET AL.or a prophylactic agent, correlates with a reduction in
viral RNA. Although ribavirin did inhibit the replication of
YFV, DENV, and MODV in vitro, the drug was not potent
enough to inhibit the replication of the virus in infected
SCID mice and hamsters (i.e., neither a delay in virus-
induced morbidity and mortality nor a reduction in viral
RNA was observed). This is in agreement with the lack of
activity of ribavirin against experimental infections with
DENV or YFV in monkeys (Huggins, 1989; Malinoski et
l., 1990). Because of the absence of any activity of
ibavirin in the Modoc model, we decided to study
hether the interferon inducer poly IC delays or prevents
irus-induced mortality and, if so, whether this correlates
ith a reduction in viral RNA load. Poly IC was previously
hown to elicit a protective effect against JEV in mice and
onkeys (Singh and Postic, 1970; Worthington et al.,
973; Harrington et al., 1977). Pretreatment of infected
CID mice with poly IC resulted in a significant delay in
irus-induced mortality, which correlated with a marked
eduction in viral RNA load in infected organs. These
indings demonstrate that the Modoc virus model may be
onvenient for antiviral drug study purposes.
In conclusion, the Modoc models in SCID mice and
amsters may offer the possibility of evaluating novel
trategies for the treatment of infections with flaviviruses,
ncluding Flavivirus-induced encephalitis.
MATERIALS AND METHODS
ells and viruses
African green monkey kidney (Vero) cells were grown
n minimum essential medium (MEM; Gibco, Paisley,
cotland) supplemented with 10% inactivated fetal calf
erum (FCS; Integro, Zaandam, Holland), 1% L-glutamine,
and 0.3% bicarbonate. MODV (ATCC VR-537) was ob-
tained from the American Type Culture Collection (ATCC,
Rockville, MD). The cytopathic dengue virus serotype 2
(strain New Guinea) was kindly provided by Dr. V. Deubel
(Institut Pasteur, Paris, France) and the yellow fever virus
used was the vaccine strain Stamaril (Pasteur Merieux).
All viruses were propagated in Vero cells at 37°C. Con-
fluent cultures of Vero cells were infected with the dif-
ferent viruses and incubated at 37°C until extensive CPE
was observed (generally 7–9 days postinfection). At that
time, culture medium was collected, cell debris was
pelleted by centrifugation, and the supernatant was ali-
quoted and stored at 280°C.
nimals
Eight- to 12-week-old Gold hamsters and SCID (severe
ombined immunodeficiency) or NMRI mice (weighing
6–20 g) were used throughout the experiments. All an-mals were bred at the Rega Institute (the SCID mice
nder germ-free conditions).ompounds
Mycophenolic acid (MPA) was purchased from Sigma
St. Louis, MO) and ribavirin [1-(b-D-ribofuranosyl)-1,2,4-
triazole-3-carboxamide] was from ICN (Costa Mesa, CA).
EICAR (5-ethynyl-1-b-D-ribofuranosylimidazole-4-carbox-
amide) was synthesized by Dr. A. Matsuda (Hokkaido
University, Sapporo, Japan). Tiazofurin was provided by
Dr. R. Cooney and Dr. D. G. Johns (National Cancer
Institute, NIH, Bethesda, MD). Poly inosinic-polycytidilic
acid (Poly IC) was purchased from Sigma.
Plaque-reduction assay
Serial dilutions of the test compounds were added to
confluent Vero cell cultures that were grown in 96-well
microtiter trays. Cells were infected with approximately
20 PFU (plaque-forming units) of either YFV, DENV, or
MODV. Cultures were further incubated at 37°C for 7
days, after which they were fixed with 70% ethanol and
stained with a 2% Giemsa solution. Plaques were then
counted under an inverted microscope. The antiviral ac-
tivity of the compounds is expressed as the 50% effective
concentration (EC50) or the concentration required to
reduce plaque formation by 50%.
Titration for infectious virus content
Animals were killed by ether anesthesia, spleen and
brain were dissected aseptically, and 10% (w/v) tissue
homogenates were prepared in MEM supplemented
with 2% FCS. Confluent Vero cell cultures grown in 96-
well trays were infected with 10-fold serial dilutions of
the tissue homogenates and incubated at 37°C for 1 h,
after which the inoculum was removed. Cultures were
then washed twice with warm medium and further incu-
bated at 37°C for 7–9 days, after which the cultures were
evaluated for virus-induced cytopathic effect and titer
was expressed in cell culture infective dose 50 (CCID50).
RT-PCR
Viral RNA was extracted from 140 ml of either cell
culture supernatant or urine of infected animals using
the QIAamp Viral RNA kit (QIAgen, Hilten, Germany). For
the isolation of RNA from cell cultures, cell debris was
first spun down with two consecutive centrifugation
steps at 3500 rpm in a Minifuge-T. For the isolation of
RNA from tissue samples, the RNeasy Mini kit (Qiagen)
was used. The following reaction mixture was prepared
for the reverse transcription step: 31.5 ml purified RNA; 10
ml of 53 RT-buffer (Amersham, Roosendaal, Belgium);
dATP, dGTP, dCTP, and dTTP, each at a final concentra-
tion of 0.5 mM; and 1.2 mM VD8 primer (59-GGGTCTC-
CTCTAACCTCTAG-39). Following a 1-min incubation of
the RNA template at 94°C, annealing of the primer was
allowed to proceed at room temperature. Subsequently,
2.5 ml enzyme mixture was added, consisting of 1.35 ml
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35MODOC VIRUS INFECTIONSRNase-free water, 95 units HPRI ribonuclease inhibitor
(Amersham), and 3.75 units RAV-2 reverse transcriptase
(Amersham). The mixture was incubated at 45°C for
1.5 h. The PCR reaction mixture was prepared as follows:
35.3 ml DNase-free water, 5 ml cDNA, 5 ml 103 PCR-
uffer, 2 ml dNTP-mix (100 mM of each dNTP), 1.2 mM
primer VD8, 1.2 mM primer EMF1 [59-TGGATGACSACK-
GARGAYATG-39 (S 5 C/G, K 5 T/G, R 5 A/G, Y 5 C/T)]
ere mixed with 3.5 units Super TAQ (HT Biotechnology,
ambridge, UK). The following PCR program was run
Thermocycler Techne; Progene, Cambridge, UK): 5 min
t 95°C, 30 cycles of 45 s at 95°C, 45 s at 50°C, 45 s at
2°C, and for the final extension 5 min at 72°C. EMF1
nd VD8 are universal Flavivirus primers that anneal in
ery conserved regions of the NS5 protein and the 39
TR, respectively (Pierre et al., 1994).
emiquantitative RT-PCR
A calculated amount of 15 ng of total RNA isolated
rom tissue fragments was used in a semiquantitative
T-PCR assay using the OneStep RT-PCR Kit (Qiagen).
APDH served as an internal control and a primer ratio
ODV/GAPDH of 2/1 was used, as recommended by the
anufacturer. Amplification primers were GAPDH for-
ard primer: 59-GGT GAA GGT CGG TGT GAA CG-39;
GAPDH reversed primer: 59-ATG TTC TGG ACA ACC
CCA CG-39; MODV forward primer: 59-GGG TGC TAA
CTT GGA TGT GGA-39; MODV reversed primer: 59-GGG
CTG TTG GCA TTG ATT CTT-39. After amplification (an-
nealing at 64°C, 30 cycles) and separation of the ampli-
cons (GAPDH: 609 b, MODV 743 b) by agarose gel
electrophoresis, the gel was scanned and the two bands
were quantified using the ImageMaster program (Hoeffer
Pharmacia Biotech, Uppsala, Sweden).
Quantification of Modoc virus RNA by 59-nuclease
real-time RT-PCR
RNA preparation was performed using the Qiagen
Viral RNA Kit (Qiagen) according to the manufacturer’s
instructions. For elution of RNA, the columns were incu-
bated with 50 ml of RNase-free water at 80°C. Primers
ModS1 (59-CCA GGA CAA GTC ATG TGG TAG C-93) and
odAS1 (59-TCC CAA AGA TGT TCC TCA CCT T-39) were
sed to amplify a 101-bp segment in the NS5 region of
odoc virus. For detection of PCR products, probe
odP1 (59-CAG AAT GGG CCA AGT TGC TTC CAG T-39)
was used. It was labeled with FAM (6-carboxy-fluores-
cein) at the 59-end and TAMRA (6-carboxy-N,N,N9/,N9-
tetramethylrhodamine) at the 39-end. The probe was
phosphorylated at its 39-end to prevent elongation during
PCR. RT-PCR was done using the Platinum RT-PCR Ther-
moScript One-Step System (Life Technologies,
Karlsruhe, Germany). A 20-ml reaction volume contained
10 ml of 23 reaction buffer, 280 nM each of primers
ModS1 and ModAS1, 140 nM of probe ModP1, 0.8 mgBSA (Sigma-Aldrich, Munich, Germany), and 0.4 ml of
ThermoScript Reverse Transcriptase/Platinum Taq En-
zyme mix. Prepared RNA (2 ml) was added to each
reaction. Thermal cycling in a LightCycler (Roche Molec-
ular Biochemicals, Mannheim, Germany) involved re-
verse transcription at 55°C for 20 min, denaturation at
95°C for 5 min, and 40 cycles of 95°C for 5 s and 60°C
for 20 s (Wittwer et al., 1997).
In the course of PCR, probe ModP1 was digested by
59-nuclease activity of Taq DNA polymerase when spe-
cifically annealed to a generated Modoc PCR-product
(Holland et al., 1991). Probe-digestion liberated the FAM
rom the TAMRA dye, causing an increase in FAM-spe-
ific fluorescence during PCR (Livak et al., 1995). FAM
luorescence was measured on detection channel F1
530 nm) and divided by fluorescence measured on
hannel F2 (640 nm) for normalization. As a quantifica-
ion standard for real-time PCR, a strong positive Modoc
irus stock was diluted in negative human plasma prior
o RNA preparation. The amount of one PCR-unit of
odoc RNA was defined to be the lowest possible dilu-
ion step that could be amplified in five of five replicate
eactions. The quantification procedure using the Light-
ycler was previously described (De Silva et al., 1998).
rine samples were analyzed in two replicate reactions
nd tissue samples, in four.
nimal experiments
SCID mice or NMRI mice were inoculated with 104
PFU of MODV via either the intraperitoneal (i.p., 200 ml),
intracerebral (i.c., 50 ml), or intranasal route (i.n., 20 ml).
The animals were examined daily for signs of morbidity
and mortality. Statistical significance of differences in the
mean day of death was assessed by means of the
Student’s t test and differences in the number of survivals
by means of the x2 test. To study the progression of
MODV infection in SCID mice, the animals were infected
intraperitoneally with MODV and two mice were termi-
nated daily. Brain, salivary glands, lung, liver, kidney, and
spleen were removed and total RNA was extracted from
these organs and subsequently used for RT-PCR. Eight-
to 12-week-old hamsters were infected intraperitoneally
with 104 PFU of MODV. At least three animals were used
for each experimental condition. The animals were
housed individually in metabolic cages. Urine samples
were collected daily and RNA was extracted and subse-
quently used for RT-PCR.
Histology, histopathology, and electron microscopy
Vero cells that had been infected with MODV and that
exhibited an extensive cytopathic effect were fixed in a
buffered glutaraldehyde solution for 30 min, washed with
isotonic phosphate buffer, postfixed with a 1% OsO4
solution for 1 h, collected, dehydrated, and embedded in
Dow epoxy resin for electron microscopy. Sections (1
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36 LEYSSEN ET AL.mm) stained with toluidin blue were examined with a light
microscope. Sample sections (50 nm) of areas of interest
were collected on grids, stained with uranyl acetate and
lead citrate, and examined with a Philips CM10 electron
microscope. Moribund animals with severe signs of pa-
ralysis were terminated by ether anesthesia and were
transcardially perfused with 20 ml of a buffered 4% form-
aldehyde solution for histology or with 20 ml of buffered
2.5% glutaraldehyde solution for electron microscopical
purposes. Organs were processed as described above.
For histology, fixed tissue samples were embedded in
paraffin and sections were stained with hematoxylin and
eosin (H&E) according to standard procedures.
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